MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 74 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2021. The put-call ratio across all filers is 4.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,476,984 | -31.1% | 7,747,891 | -26.9% | 0.11% | -28.9% |
| Q4 2022 | $7,954,142 | -12.9% | 10,605,522 | 0.0% | 0.15% | -10.6% |
| Q3 2022 | $9,132,000 | -16.0% | 10,605,522 | +9.2% | 0.17% | -13.7% |
| Q2 2022 | $10,877,000 | -43.7% | 9,711,422 | -43.8% | 0.20% | -37.1% |
| Q1 2022 | $19,336,000 | -30.0% | 17,264,764 | 0.0% | 0.31% | -11.8% |
| Q4 2021 | $27,624,000 | -33.9% | 17,264,764 | 0.0% | 0.36% | -22.7% |
| Q3 2021 | $41,781,000 | -23.7% | 17,264,764 | 0.0% | 0.46% | -17.1% |
| Q2 2021 | $54,730,000 | -5.9% | 17,264,764 | +0.0% | 0.55% | +1.8% |
| Q1 2021 | $58,183,000 | +17.6% | 17,264,763 | +25.0% | 0.54% | +25.6% |
| Q4 2020 | $49,463,000 | – | 13,816,488 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,029,649 | $12,331,000 | 0.54% |
| Vivo Capital, LLC | 778,000 | $2,381,000 | 0.17% |
| Logos Global Management LP | 200,000 | $612,000 | 0.12% |
| DAFNA Capital Management LLC | 76,800 | $235,000 | 0.07% |
| Verition Fund Management LLC | 395,290 | $1,210,000 | 0.04% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 250,000 | $765,000 | 0.02% |
| CSS LLC/IL | 54,773 | $168,000 | 0.01% |
| Point72 Asset Management, L.P. | 375,000 | $1,148,000 | 0.01% |
| Marshall Wace North America L.P. | 267,180 | $818,000 | 0.01% |
| HHLR ADVISORS, LTD. | 124,970 | $382,000 | 0.00% |